Loncar Debuts ETF to Play China’s Biotech, Pharma Companies
Loncar Investments has partnered up with Exchange Traded Concepts to launch a new ETF that tracks the growing biopharmaceutical sector in China.…
Biotechnology
Biotech ETFs Rally as Illumina Tops Q2 Expectations
Biotechnology sector ETFs were among the best performers Tuesday, with Illumina (NasdaqGS: ILMN) shares surging after the genomics firm beat second-quarter expectations…
Biotech ETFs Climb on Biogen’s Promising Clinical Trial
Biotech ETFs rallied Friday after Biogen (NasdaqGS: BIIB) announced successful results from its Alzheimer’s drug trial. On Friday, large-cap biotechnology sector ETFs…
Sarepta Therapeutics Helps Biotech ETFs Buck Market Trend
Biotechnology sector-related exchange traded funds were among the few areas of the markets that shook off the tariffs-talk volatility and was still…
The Mind Controlled Bionic Arm
Did you know there is a mind controlled bionic arm? In the first episode of Humans+, Motherboard dives into the world of…
An ETF to Capture Genomic Sequencing Innovation
ETF investors interested in the growth opportunities found in the biotechnology segment can look to initiatives in the health care segment, such…
As Genome-Editing Evolves, So Do The Investment Opportunities
The health care industry is experiencing innovative developments that can advance our society and produce vast growth potential. On the upcoming webcast,…
6 Top Healthcare ETFs Rally as Trump Vows End to ‘Global Freeloading’
Healthcare stocks and top healthcare ETFs rallied Friday after President Donald Trump vowed to end to “global freeloading” that has allowed foreign…
Healthcare ETFs Lag Markets as Celgene Drags
Healthcare stocks and healthcare ETFs were among the worst performing areas of the S&P 500 Monday as Celgene (NasdaqGS: CELG) shares plunged…
Big Biotech ETF Can Bounce Back
The iShares Nasdaq Biotechnology ETF (NASDAQGM: IBB), the largest biotech exchange traded fund by assets, and other biotechnology assets have recently been slumping,…
Catalysts Abound for Biotech ETFs
Biotechnology stocks and biotech ETFs tumbled in the back half of March and to start April. For example, the SPDR S&P Biotech…
Alkermes FDA Refusal: Biotech ETFs Dragged Down
Biotechnology stocks and biotech ETFs were among the worst performing areas of the markets Monday as Alkermes (NasdaqGS: ALKS) shares plunged after…
Betting Big on Biotech ETFs? Traders Leverage ETFs
With biotechnology stocks and ETFs expected to remain areas of interest throughout 2018, risk-tolerant traders may want to consider examining leveraged ETFs…
Biotech ETFs Pop on Celgene, Juno Deal
Biotechnology sector-related ETFs surged Monday after Celgene (NasdaqGS: CELG) said it will acquire Juno Therapeutics (NasdaqGS: JUNO) to expand its cancer treatment…